Our product, Nichi glucan, has been published in NutraIngredients-Asia, which is a collection of information on functional foods and suppliments in Asia and the Middle East.
It reports that a clinical trial has started in India to use Nichi glucan as an adjunct in the treatment of Covid-19 patients.
To read the NutraIngredients-Asia article, please click here.
Please visit nichiglucan.com for more information about Nichi Glucan.
Sri Ramachandra Institute team triumphs in the FCQ of NCRM NICHE 2024 02 Dec 2024 Winners of the XIX Fujio Cup
A global recognition to our 16-year long research outcome! 30 Nov 2024 In the Genito-Urinary Reconstructive Su
Clinical study results of Neu REFIX B-glucans & research updates by Dr. K. Raghavan 06 Oct 2024 Dr. Raghav
Neu REFIX pre-clinical studies in mdx mice @ AOMC-JMS 2024 05 Oct 2024 Disease modifying approach in managing
At International Conference in Yokohama, Japan 17 Aug 2024 Nichi BRITE Beta glucan administration resulted in
At the MENA Conference on Rare DiData presented in IFPA 7th World Psoriasis conference, in Stockholm, Sweden 0
Cliny PEG Gastrostomy kits of Create Medic launched in India by Medinippon, GNCorp sister company 11Aug2023 Ja
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine (NCRM) have reported an increased yield of Beta 1,3-1,6 glucans in the produc
